UK Generics Market Analysis
Format : Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Apr, 2011| No. of Pages : 55
List of Figures:
Figure 3-1: Pharmaceutical Market (Billion GBP), 2009 & 2010
Figure 3-2: Forecast for Pharmaceutical Market (Billion GBP), 2011-2013
Figure 3-3: Share of Generics in Pharma Market (%), 2010
Figure 3-4: Forecast for Share of Generics in Pharma Market (%), 2013
Figure 4-1: Population Aged 65 and Above (Million), 2009-2013
Figure 5-1: Generics Market (Billion GBP), 2009-2013
Figure 5-2: Total Number of Prescriptions (Million), 2009-2013
Figure 5-3: Net Ingredient Cost of Prescriptions (Million GBP), 2005-2009
Figure 5-4: Share of Generics Prescriptions in Total Prescriptions (2009)
Figure 5-5: Analgesics Market (Million GBP), 2010 & 2013
List of Tables:
Table 3-1: Healthcare Statistics (2008-2010)
Table 3-2: Forecast for Healthcare Statistics (2011-2013)
Table 4-1: Blockbuster Drugs Going Off-patent (2011-2013)
Table 5-1: Top 10 Most Prescribed Generic Drugs (Million), 2010
Table 7-1: Currently Approved Biosimilar Products in EU
Table 8-1: Teva Pharmaceuticals - SWOT Analysis
Table 8-2: Sandoz - SWOT Analysis
Table 8-3: Actavis UK Ltd. - SWOT Analysis
Table 8-4: Hikma Pharmaceuticals - SWOT Analysis